Brief: Promore Pharma Q4 Operating Loss Narrows To SEK 6.9 Mln

PMD Device Solutions AB

23/02/2021 13:34

Feb 23 (Reuters) - Promore Pharma AB  PROMO.ST :
    * YEAR-END REPORT 2020
    * Q4 NET SALES AMOUNTED TO MSEK 0 (1.5)
    * Q4 OPERATING LOSS FOR PERIOD WAS MSEK -6.9 (-9.4)
    * MANAGEMENT AND BOARD ARE CURRENTLY PERFORMING A
COMPREHENSIVE
EVALUATION OF STRATEGIC ALTERNATIVES WITHIN MAIN PROJECTS
    * AIM IS TO ANNOUNCE THIS REVISED STRATEGY DURING
MARCH/APRIL 2021

Source text for Eikon:  ID:nMFN9LQ1Nw 
Further company coverage:  PROMO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))